RU-24,969
| RU-24,969 | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
RU-24,969 is an experimental drug that has been studied for its potential effects on the central nervous system. It is a member of the phenethylamine class of compounds and is structurally related to other psychoactive substances.
Chemical Structure and Properties[edit]
RU-24,969 is chemically known as 1-(2,5-Dimethoxy-4-methylphenyl)-2-aminopropane. It has a molecular formula of C11H17NO2. The compound features a phenyl ring substituted with two methoxy groups and a methyl group, along with an amino group attached to a propyl chain.
Pharmacology[edit]
The pharmacological profile of RU-24,969 suggests that it acts as a serotonin receptor agonist. It has been shown to have high affinity for the 5-HT2A receptor, which is implicated in the modulation of mood, perception, and cognition. The drug's interaction with this receptor is believed to underlie its psychoactive effects.
Research and Potential Applications[edit]
Research on RU-24,969 has primarily focused on its potential use in studying the serotonergic system and its role in various neuropsychiatric disorders. Studies have explored its effects on behavior, neurotransmitter release, and receptor binding in animal models. However, its use in humans has not been extensively studied, and it remains a compound of interest for further research.
Safety and Legal Status[edit]
As an experimental drug, RU-24,969 has not been approved for medical use. Its safety profile has not been fully established, and it is not regulated under any specific legal framework. Researchers handling this compound must adhere to appropriate safety protocols and regulatory guidelines.
See Also[edit]
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
